Cargando…

Cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis

Dialysis‐related adverse reactions can be serious and difficult to predict. In our case, nafamostat mesylate (NM) was thought to be the cause of cardiopulmonary arrest (CPA) due to NM‐induced anaphylaxis but was not reflected in the allergy tests. Rare but life‐threatening drawbacks occur immediatel...

Descripción completa

Detalles Bibliográficos
Autores principales: Shioya, Nobuki, Inoue, Nozomu, Sato, Hiroki, Iwahara, Motoko, Sato, Tomohiro, Tsukamoto, Yuki, Naito, Yuki, Hazama, Kohji, Shichinohe, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314566/
https://www.ncbi.nlm.nih.gov/pubmed/35903505
http://dx.doi.org/10.1002/ccr3.6140
_version_ 1784754346924179456
author Shioya, Nobuki
Inoue, Nozomu
Sato, Hiroki
Iwahara, Motoko
Sato, Tomohiro
Tsukamoto, Yuki
Naito, Yuki
Hazama, Kohji
Shichinohe, Yasuo
author_facet Shioya, Nobuki
Inoue, Nozomu
Sato, Hiroki
Iwahara, Motoko
Sato, Tomohiro
Tsukamoto, Yuki
Naito, Yuki
Hazama, Kohji
Shichinohe, Yasuo
author_sort Shioya, Nobuki
collection PubMed
description Dialysis‐related adverse reactions can be serious and difficult to predict. In our case, nafamostat mesylate (NM) was thought to be the cause of cardiopulmonary arrest (CPA) due to NM‐induced anaphylaxis but was not reflected in the allergy tests. Rare but life‐threatening drawbacks occur immediately after hemodialysis initiation.
format Online
Article
Text
id pubmed-9314566
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93145662022-07-27 Cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis Shioya, Nobuki Inoue, Nozomu Sato, Hiroki Iwahara, Motoko Sato, Tomohiro Tsukamoto, Yuki Naito, Yuki Hazama, Kohji Shichinohe, Yasuo Clin Case Rep Case Report Dialysis‐related adverse reactions can be serious and difficult to predict. In our case, nafamostat mesylate (NM) was thought to be the cause of cardiopulmonary arrest (CPA) due to NM‐induced anaphylaxis but was not reflected in the allergy tests. Rare but life‐threatening drawbacks occur immediately after hemodialysis initiation. John Wiley and Sons Inc. 2022-07-25 /pmc/articles/PMC9314566/ /pubmed/35903505 http://dx.doi.org/10.1002/ccr3.6140 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Shioya, Nobuki
Inoue, Nozomu
Sato, Hiroki
Iwahara, Motoko
Sato, Tomohiro
Tsukamoto, Yuki
Naito, Yuki
Hazama, Kohji
Shichinohe, Yasuo
Cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis
title Cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis
title_full Cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis
title_fullStr Cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis
title_full_unstemmed Cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis
title_short Cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis
title_sort cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314566/
https://www.ncbi.nlm.nih.gov/pubmed/35903505
http://dx.doi.org/10.1002/ccr3.6140
work_keys_str_mv AT shioyanobuki cardiopulmonaryarrestcausedbynafamostatmesylateduringhemodialysis
AT inouenozomu cardiopulmonaryarrestcausedbynafamostatmesylateduringhemodialysis
AT satohiroki cardiopulmonaryarrestcausedbynafamostatmesylateduringhemodialysis
AT iwaharamotoko cardiopulmonaryarrestcausedbynafamostatmesylateduringhemodialysis
AT satotomohiro cardiopulmonaryarrestcausedbynafamostatmesylateduringhemodialysis
AT tsukamotoyuki cardiopulmonaryarrestcausedbynafamostatmesylateduringhemodialysis
AT naitoyuki cardiopulmonaryarrestcausedbynafamostatmesylateduringhemodialysis
AT hazamakohji cardiopulmonaryarrestcausedbynafamostatmesylateduringhemodialysis
AT shichinoheyasuo cardiopulmonaryarrestcausedbynafamostatmesylateduringhemodialysis